BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with FDA Reverses 2023 Peptide Ban: 12 Peptides Back for Review TikTok FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures Chattanooga Times Free Press FDA moves toward easing restrictions on certain peptides BioPharma Dive The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York